Last updated on April 2018

A clinical trial seeking patients for a research study for the treatment of Ankylosing spondylitis


Brief description of study

This is a multicenter, Phase 2, double-blind, placebo-controlled study in subjects with active Ankylosing Spondylitis (AS). A total of approximately 100 subjects will be randomized to one of 2 treatment arms in a 1:1 ratio: oral filgotinib tablets q.d. or matching placebo q.d. Treatment duration will be 12 weeks. Each subject will stay in the study for a maximum of 20 weeks (from Screening visit to Follow-up visit).

Clinical Study Identifier: NCT03117270

Contact Investigators or Research Sites near you

Start Over

ULB Hopital Erasme, Service de Rheumatology
Brussels, Belgium

UMHAT Kaspela EOOD
Plovdiv, Bulgaria

Revmatologicka ambulance
Ostrava, Czechia

CCBR Czech, a.s
Pardubice, Czechia

Medical Center "Teodora", EOOD
Ruse, Bulgaria

UMHAT "SofiaMed", OOD, Block 1
Sofia, Bulgaria

Eurohospital
Plovdiv, Bulgaria

Akademik Ivan Geshov, UMHAT "Sv. Ivan Rilski", EAD
Sofia, Bulgaria

Clinic of Rheumatology, UMHAT "Sv. Ivan Rilski", EAD
Sofia, Bulgaria

Medical Center "Nov Rehabilitatsionen Tsentar", EOOD
Stara Zagora, Bulgaria